Preliminary Efficacy and Safety of 8-Week Glecaprevir/Pibrentasvir in Patients with HCV Genotype 1-6 Infection and Compensated Cirrhosis: The Expedition-8 Study

被引：0

作者：

Brown, Robert S., Jr. ^{[1
]}

Hezode, Christophe ^{[2
]}

Wang, Stanley ^{[3
]}

Buti, Maria ^{[4
,5
]}

Chuang, Wan-Long ^{[6
,7
]}

Aguilar, Humberto I. ^{[8
]}

Horvath, Gabor ^{[9
]}

Rosado-Carrion, Barbara ^{[10
]}

Rodriguez-Perez, Federico ^{[11
,12
]}

Cohen, Eric ^{[3
]}

Hui, Yiran B. ^{[3
]}

Schnell, Gretja ^{[3
]}

Lin, Chih-Wei ^{[3
]}

Rodrigues, Lino, Jr. ^{[3
]}

Trinh, Roger ^{[3
]}

Mensa, Federico J. ^{[3
]}

Felizarta, Franco

机构：

[1] New York Presbyterian Hosp, Cornell Med Coll, Dept Med, Ctr Liver Desease & Transplantat, Nyc, NY USA

[2] Univ Paris Est, Hop Henri Mondor, Dept Hepatol, Paris, France

[3] Abbvie Inc, N Chicago, IL USA

[4] Hosp Univ Vall dHebron, Barcelona, Spain

[5] Vall DHebron Univ Hosp, Liver Unit, Barcelona, Spain

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[7] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[8] Louisiana Res Ctr, Shreveport, LA USA

[9] Hepatol Ctr Buda, Budapest, Hungary

[10] Ghgcpr Res Inst, Ponce, PR USA

[11] Ghwc, San Juan, PR USA

[12] Gastroenterol Sect, San Juan, PR USA

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

715A

引用

页码：425A / 426A

页数：2

共 50 条

[1] Preliminary Efficacy and Safety of 8-Week Glecaprevir/Pibrentasvir in Patients with HCV Genotype 1-6 Infection and Compensated Cirrhosis: The Expedition-8 Study
Brown, Robert S., Jr.
Hezode, Christophe
Wang, Stanley
Buti, Maria
Chuang, Wan-Long
Aguilar, Humberto I.
Horvath, Gabor
Rosado-Carrion, Barbara
Rodriguez-Perez, Federico
Cohen, Eric
Hu, Yiran B.
Schnell, Gretja
Lin, Chih-Wei
Rodrigues, Lino, Jr.
Trinh, Roger
Mensa, Federico J.
Felizarta, Franco
HEPATOLOGY, 2018, 68 (06) : 1450A - 1451A
[2] PRELIMINARY EFFICACY AND SAFETY OF 8-WEEK GLECAPREVIR/PIBRENTASVIR IN PATIENTS WITH HCV GENOTYPE 1-6 INFECTION AND COMPENSATED CIRRHOSIS: THE EXPEDITION-8 STUDY
Brown, Robert S., Jr.
Hezode, Christopher
Wang, Stanley
Buti, Maria
Chuang, Wan-Long
Aguilar, Humberto
Horvath, Gabor
Carrion, Barbara Rosado
Rodriguez-Perez, Federico
Cohen, Eric
Hu, Yiran B.
Schnell, Gretja
Lin, Chih-Wei
Rodrigues, Lino
Trinh, Roger
Mensa, Federico J.
GUT, 2019, 68 : A146 - A146
[3] Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial
Brown, Robert S., Jr.
Buti, Maria
Rodrigues, Lino
Chulanov, Vladimir
Chuang, Wan-Long
Aguilar, Humberto
Horvath, Gabor
Zuckerman, Elimelech
Carrion, Barbara Rosado
Rodriguez-Perez, Federico
Urbanek, Petr
Abergel, Armand
Cohen, Eric
Lovell, Sandra S.
Schnell, Gretja
Lin, Chih-Wei
Zha, Jiuhong
Wang, Stanley
Trinh, Roger
Mensa, Federico J.
Burroughs, Margaret
Felizarta, Franco
JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 441 - 449
[4] EFFICACY AND SAFETY OF 8-WEEK GLECAPREVIR/PIBRENTASVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1, 2, 3, 4, 5, OR 6 INFECTION AND COMPENSATED CIRRHOSIS: EXPEDITION-8 COMPLETE RESULTS
Brown, Robert S., Jr.
Buti, Maria
Rodrigues, Lino
Chulanov, Vladimir
Chuang, Wan Long
Aguilar, Humberto
Horvath, Gabor
Zuckerman, Elimelech
Rosado-Carrion, Barbara
Rodriguez-Perez, Federico
Urbanek, Petr
Abergel, Armand
Cohen, Eric
Lovell, Sandra Sinisi
Schnell, Gretja
Lin, Chih-Wei
Zha, Jiuhong
Wang, Stanley
Trinh, Roger
Mensa, Federico J.
Burroughs, Margaret
Felizarta, Franco
HEPATOLOGY, 2019, 70 (06) : 1493A - 1494A
[5] High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis
Puoti, Massimo
Foster, Graham R.
Wang, Stanley
Mutimer, David
Gane, Edward
Moreno, Christophe
Chang, Ting Tsung
Lee, Samuel S.
Marinho, Rui
Dufour, Jean-Francois
Pol, Stanislas
Hezode, Christophe
Gordon, Stuart C.
Strasser, Simone I.
Thuluvath, Paul J.
Zhang, Zhenzhen
Lovell, Sandra
Pilot-Matias, Tami
Mensa, Federico J.
JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 293 - 300
[6] EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN RENALLY-IMPAIRED PATIENTS WITH CHRONIC HCV GENOTYPE 1-6 INFECTION
Lawitz, Eric
Flisiak, Robert
Abunimeh, Manal
Sise, Meghan
Park, Jun Yong
Kaskas, Marwan
Bruchfeld, Annette
Worns, Marcus-Alexander
Aglitti, Andrea
Xue, Zhenyi
Rullman, Janean
Porcalla, Ariel R.
Cohen, Eric
Trinh, Roger N.
Persico, Marcello
GASTROENTEROLOGY, 2018, 154 (06) : S1104 - S1105
[7] Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry
Hung, Chao-Hung
Chang, Te-Sheng
Huang, Chung-Feng
Kuo, Hsing-Tao
Lo, Ching-Chu
Huang, Chien-Wei
Chong, Lee-Won
Cheng, Pin-Nan
Yeh, Ming-Lun
Peng, Cheng-Yuan
Cheng, Chien-Yu
Huang, Jee-Fu
Bair, Ming-Jong
Lin, Chih-Lang
Yang, Chi-Chieh
Wang, Sih-Ren
Hsieh, Tsai-Yuan
Lee, Tzong-Hsi
Lee, Pei-Lun
Wu, Wen-Chih
Lin, Chih-Lin
Su, Wei-Wen
Yang, Shengshun
Wang, Chia-Chi
Hu, Jui-Ting
Mou, Lien-Juei
Chen, Chun-Ting
Huang, Yi-Hsiang
Chang, Chun-Chao
Huang, Jia-Sheng
Chen, Guei-Ying
Gao, Jian-Neng
Tai, Chi-Ming
Liu, Chun-Jen
Lee, Mei-Hsuan
Tsai, Pei-Chien
Dai, Chia-Yen
Kao, Jia-Horng
Lin, Han-Chieh
Chuang, Wan-Long
Chen, Chiyi
Tseng, Kuo-Chih
Yu, Ming-Lung
JOURNAL OF HEPATOLOGY, 2022, 77 : S595 - S596
[8] Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir to Treat HCV Genotype 1-6 Infection in Patients Without Cirrhosis Including HIV Co-Infection
Bernstein, David E.
Foster, Graham
Dylla, Douglas
Mauss, Stefan
Nelson, David
Asselah, Tarik
Flamm, Steven
Cooper, Curtis
Liu, Ran
Viani, Rolando
Wang, Stanley
Mensa, Federico
Sulkowski, Mark
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S490 - S490
[9] Safety and efficacy of glecaprevir/pibrentasvir for the treatment of HCV genotype 1-6: Results of the HCV-TARGET study
Sterling, Richard
Zeuzem, Stefan
Welzel, Tania
Manns, Michael P.
Reddy, Rajender
Terrault, Norah
Ben Ari, Ziv
Vodkin, Irine
Toor, Arifa
Vainorius, Monika
Akushevich, Lucy
Fried, Michael W.
Nelson, David R.
Sulkowski, Mark
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E241 - E242
[10] SAFETY AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR FOR THE TREATMENT OF HCV GENOTYPE 1-6: RESULTS OF THE HCV-TARGET STUDY
Sterling, Richard K.
Zeuzem, Stefan
Welzel, Tania M.
Manns, Michael
Reddy, K. Rajender
Terrault, Norah
Ben-Ari, Ziv
Vodkin, Irine
Toor, Arifa
Vainorius, Monika
Akushevich, Lucy
Fried, Michael W.
Nelson, David R.
Sulkowski, Mark S.
GASTROENTEROLOGY, 2019, 156 (06) : S1220 - S1220

← 1 2 3 4 5 →